Literature DB >> 668787

Inter- and intra-individual variation in the metabolism of methaqualone in man after a single oral dose.

K Wilson, C N Reynolds, D Burnett.   

Abstract

The urinary excretion of five C-monohydroxy metabolites and the N-oxide metabolite of methaqualone in the 24 h period immediately after oral dosing with 250 mg methaqualone (Melsed) has been measured in ninteen healthy adults (13 male, 6 female) to assess interindividual variations and in five adults (3 male, 2 female) on five separate occasions to assess intraindividual variation. The overall importance of the six metabolites was 4'-hydroxy greater than N-oxide greater than 2'-hydroxymethyl greater than 3'-hydroxy greater than 6-hydroxy = 2-hydroxymethyl. Variations in this order both within the 24 h period and within each of the three eight-hour periods constituting the 24 hours were minor and variations in the absolute amount of each metabolie excreted ranged from two to three-fold. Intraindividual variations were generally smaller than interindividual variations and for each individual the pattern of metabolism was similar on the five occasions. There is evidence that the C-oxidation of methaqualone may be more sensitive to cyclical variations in hormone levels than is N-oxidation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 668787     DOI: 10.1007/BF00716365

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

Review 1.  Factors causing interindividual variations of drug concentrations in blood.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

2.  Methaqualone pharmacokinetics after single- and multiple-dose administration in man.

Authors:  R K Nayak; R D Smyth; J H Chamberlain; A Polk; A F DeLong; T Herczeg; P B Chemburkar; R S Joslin; N H Reavey-Cantwell
Journal:  J Pharmacokinet Biopharm       Date:  1974-04

3.  Plasma concentrations and effects of methaqualone after single and multiple oral doses in man.

Authors:  G Alván; O Ericsson; S Levander; J E Lindgren
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

4.  Identification of free and conjugated metabolites of methaqualone by gas chromatography-mass spectrometry.

Authors:  R Bonnichsen; Y Mårde; R Ryhage
Journal:  Clin Chem       Date:  1974-02       Impact factor: 8.327

5.  Plasma levels and absorption of methaqualone after oral administration to man.

Authors:  R N Morris; G A Gunderson; S W Babcock; J F Zaroslinski
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

6.  Determination of methaqualone in urine by metabolite detection via gas chromatography.

Authors:  R C Permisohn; L R Hilpert; L Kazyak
Journal:  J Forensic Sci       Date:  1976-01       Impact factor: 1.832

7.  Interindividual differences in rates of drug oxidation in man.

Authors:  D S Davies; S S Thorgeirsson; A Breckenridge; M Orme
Journal:  Drug Metab Dispos       Date:  1973 Jan-Feb       Impact factor: 3.922

8.  Methaqualone metabolism by rat liver microsomes.

Authors:  P Manowitz; C M Shull
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-01

9.  Urinary excretion of methaqualone-N-oxide in man.

Authors:  C N Reynolds; K Wilson; D Burnett
Journal:  Xenobiotica       Date:  1976-02       Impact factor: 1.908

10.  Regulation of drug metabolism in man by environmental chemicals and diet.

Authors:  A H Conney; E J Pantuck; K C Hsiao; R Kuntzman; A P Alvares; A Kappas
Journal:  Fed Proc       Date:  1977-04
View more
  10 in total

1.  Metabolic oxidation of methaqualone in extensive and poor metabolisers of debrisoquine.

Authors:  M Oram; K Wilson; D Burnett; S G Al-Dabbagh; J R Idle; R L Smith
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

2.  Metabolism of methaqualone in geriatric patients.

Authors:  C N Reynolds; K Wilson; D Burnett
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

Review 3.  Sex-related differences in drug disposition in man.

Authors:  K Wilson
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

4.  Sex specificity in methadone analgesia in the rat: a population pharmacokinetic and pharmacodynamic approach.

Authors:  Monica Rodriguez; M Angeles Carlos; Ignacio Ortega; Elena Suarez; Rosario Calvo; John C Lukas
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

5.  The kinetics of the urinary excretion of the N-oxide and glucuronides of methaqualone in man.

Authors:  K Wilson; D Burnett; M Oram; C T Reynolds
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

6.  The effect of age on the competitive C- and N-oxidative pathways of methaqualone in women.

Authors:  K Wilson; M Oram; D Burnett
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Oct-Dec       Impact factor: 2.441

Review 7.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

8.  The metabolism of methaqualone in patients with biliary cirrhosis or secondary carcinoma of the liver.

Authors:  D Burnett; C N Reynolds; K Wilson
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

9.  The influence of the menstrual cycle on the metabolism and clearance of methaqualone.

Authors:  K Wilson; M Oram; C E Horth; D Burnett
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

10.  The influence of oral contraceptives on the metabolism of methaqualone in man.

Authors:  M Oram; K Wilson; D Burnett
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.